|
ATP5D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.524700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.172300E-04 |
| Normal-vs-Stage2 |
5.635400E-01 |
| Normal-vs-Stage3 |
7.340000E-01 |
| Normal-vs-Stage4 |
4.527600E-01 |
| Stage1-vs-Stage2 |
5.116200E-02 |
| Stage1-vs-Stage3 |
1.356300E-03 |
| Stage1-vs-Stage4 |
4.973000E-01 |
| Stage2-vs-Stage3 |
4.530800E-01 |
| Stage2-vs-Stage4 |
6.689200E-01 |
| Stage3-vs-Stage4 |
2.993600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.617700E-03 |
| Normal-vs-AfricanAmerican |
1.910280E-02 |
| Normal-vs-Asian |
9.726800E-01 |
| Caucasian-vs-AfricanAmerican |
5.306200E-01 |
| Caucasian-vs-Asian |
5.032400E-01 |
| AfricanAmerican-vs-Asian |
4.398600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.812090E-04 |
| Normal-vs-Female |
5.174200E-01 |
| Male-vs-Female |
7.280200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.001390E-01 |
| Normal-vs-Extreme_Weight |
1.032370E-04 |
| Normal-vs-Obese |
1.548970E-01 |
| Normal-vs-Extreme_Obese |
2.044100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.327400E-01 |
| Normal_Weight-vs-Obese |
6.319200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.000000E-01 |
| Extreme_Weight-vs-Obese |
5.054000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.732800E-01 |
| Obese-vs-Extreme_Obese |
1.383760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.356200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.250000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.968200E-04 |
| Normal-vs-Age(81-100Yrs) |
7.385000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.293400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.025600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.580600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.624100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.362410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.199900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.03809999952543E-07 |
| Normal-VS-Type2 PRCC |
9.966800E-01 |
| Normal-VS-KIRP CIMP |
1.378210E-04 |
| Normal-VS-Unclassified PRCC |
3.285600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.81589999999066E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.40379999969254E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
6.312000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.506490E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.125000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.954000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.956700E-03 |
| Normal-vs-N1 |
3.526400E-02 |
| Normal-vs-N2 |
2.079900E-02 |
| N0-vs-N1 |
6.766000E-04 |
| N0-vs-N2 |
3.894000E-02 |
| N1-vs-N2 |
5.006800E-01 |
|
|
